Phase 1/2 Study of TAK-850 Subcutaneous Injection in Healthy Adults

Clinical trial NCT02313155 · COMPLETED

Trial details

NCT number: NCT02313155
Sponsor: Takeda
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Influenza Infection

Start date: 2014-12-01
Primary completion: 2015-01-01
Enrollment: 110

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.